aripiprazole mylan pharma (previously aripiprazole pharmathen)
mylan pharmaceuticals limited - aripiprazole - schizophrenia; bipolar disorder - psycholeptica - aripiprazole mylan pharma is geïndiceerd voor de behandeling van schizofrenie bij volwassenen en bij adolescenten van 15 jaar en ouder. aripiprazole mylan pharma is geïndiceerd voor de behandeling van matige tot ernstige manische episodes bij bipolaire i-stoornis en voor de preventie van een nieuwe manische episode bij volwassenen die ervaren voornamelijk manische episodes en wiens manische episodes gereageerd op aripiprazole behandeling. aripiprazole mylan pharma is geïndiceerd voor de behandeling van maximaal 12 weken van matige tot ernstige manische episodes bij bipolaire i-stoornis bij adolescenten in de leeftijd van 13 jaar en ouder.
coversyl 5 mg (exim pharma) filmomh. tabl.
exim pharma bv-srl - perindopril arginine 5 mg - eq. perindopril 3,395 mg - filmomhulde tablet - perindopril
dafalgan forte 1 g (exim pharma) bruistabl.
exim pharma bv-srl - paracetamol 1000 mg - bruistablet - paracetamol
clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - clopidogrel hydrochloride - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotische middelen - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.
steovit forte citroen 1000 mg - 800 ie (exim pharma) kauwtabl.
exim pharma bv-srl - cholecalciferol 800 ie; calciumcarbonaat 2500 mg - eq. calcium 1000 mg - kauwtablet - calcium, combinations with vitamin d and/or other drugs
pantomed 20 mg (exim pharma) maagsapresist. tabl.
exim pharma bv-srl - pantoprazolnatriumsesquihydraat - eq. pantoprazol 20 mg - maagsapresistente tablet - pantoprazole
triplixam 10 mg - 2.5 mg - 5 mg (exim pharma) filmomh. tabl.
exim pharma bv-srl - indapamide 2,5 mg; perindopril arginine 10 mg - eq. perindopril 6,79 mg; amlodipinebesilaat 6,935 mg - eq. amlodipine 5 mg - filmomhulde tablet - perindopril, amlodipine and indapamide
triplixam 10 mg - 2.5 mg - 10 mg (exim pharma) filmomh. tabl.
exim pharma bv-srl - indapamide 2,5 mg; perindopril arginine 10 mg - eq. perindopril 6,79 mg; amlodipinebesilaat 13,87 mg - eq. amlodipine 10 mg - filmomhulde tablet - perindopril, amlodipine and indapamide
xanax 0.5 mg (exim pharma) tabl.
exim pharma bv-srl - alprazolam 0,5 mg - tablet - alprazolam
xanax 1 mg (exim pharma) tabl.
exim pharma bv-srl - alprazolam 1 mg - tablet - alprazolam